CRBU: Caribou Biosciences, Inc. Stock

by  •  • Comments Off on CRBU: Caribou Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 359.45
Enterprise Value ($M) 308.29
Book Value ($M) 368.40
Book Value / Share 4.08
Price / Book 0.98
NCAV ($M) 275.03
NCAV / Share 3.05
Price / NCAV 1.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.26
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.37

Liquidity (mrq)
Quick Ratio 11.97
Current Ratio 11.97

Balance Sheet (mrq) ($M)
Current Assets 338.84
Assets 432.21
Liabilities 63.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 34.48
Operating Income -116.06
Net Income -102.07

Cash Flow Statement (mra) ($M)
Cash From Operations -93.29
Cash from Investing -68.18
Cash from Financing 154.30

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-23 13G Point72 Asset Management, L.P. 5.00 10.88
02-14 13G/A PFM Health Sciences, LP 7.30
01-25 13G/A State Street Corp 5.79 60.04
01-25 13G/A BlackRock Inc. 8.00 49.69
01-08 13G Avidity Partners Management LP 7.20
07-10 13G Pfizer Inc 7.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2023-11-17 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2023-11-17 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 225,492 812,493 27.75
2024-04-23 122,231 766,149 15.95
2024-04-22 157,379 583,609 26.97
2024-04-19 248,200 581,383 42.69

(click for more detail)

Similar Companies
COGT – Cogent Biosciences, Inc. COLL – Collegium Pharmaceutical, Inc.
CPIX – Cumberland Pharmaceuticals Inc. CRGX – CARGO Therapeutics, Inc.
CRNX – Crinetics Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io